{"id":"doi:10.1056/nejmoa2504214","kind":"article","title":"Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial","authors":["Ania M. Jastreboff","Donna H. Ryan","Harold Edward Bays","Peter Robert Ebeling","Mia Mackowski","Nisha Philipose","Leorah H. Ross","Yimeng Liu","Cassandra E Burns","Siddique A. Abbasi","Nicola Pannacciulli"],"author_count":11,"year":2025,"published":"2025-06-23","venue":"New England Journal of Medicine","cited_by":110,"doi":"10.1056/nejmoa2504214","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2504214","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2504214","updated":null,"pmid":"40549887","pmcid":null,"openalex_id":"W4411542117","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}